Additional Information
Book Details
Abstract
Educational opportunities for pediatric residents and primary care providers that contribute to increased competence in pediatric dermatology are an important component of improving the quality and efficiency of dermatologic care provided to children and adolescents. The 13 articles that comprise this issue have been selected to capture a significant proportion of the most common skindiseases that are seen in children and adolescents. They are intended to provide practical information on diagnosis and initial management that can be performed by the primary care provider and to provide a framework for allowing for more active involvement by the primary care provider with regards to ongoing management of these conditions. From atopic dermatitis to vitiligo, the pediatric primary care provider is guaranteed to see these conditions in their practice.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Pediatric Dermatology | i | ||
| copyright\r | ii | ||
| Contributors | v | ||
| Contents | vii | ||
| Pediatric Clinics Of\rNorth America\r | xi | ||
| Foreword | xiii | ||
| Preface\r | xv | ||
| References | xvi | ||
| Atopic Dermatitis | 241 | ||
| Key points | 241 | ||
| Overview | 241 | ||
| Epidemiology | 241 | ||
| Pathophysiology | 242 | ||
| Prevention and prognosis | 242 | ||
| Presentation | 242 | ||
| History | 242 | ||
| Physical Examination | 243 | ||
| Supporting Features | 247 | ||
| Comorbidities | 247 | ||
| Differential diagnosis | 247 | ||
| Workup/Diagnosis | 248 | ||
| Histology | 248 | ||
| Laboratory Studies | 248 | ||
| Complications | 248 | ||
| Infection | 248 | ||
| Psychosocial Impact | 250 | ||
| Therapeutic recommendations | 250 | ||
| Parent and Patient Counseling | 252 | ||
| Good Skin Care | 252 | ||
| Avoidance of Triggers | 253 | ||
| Topical CSs | 253 | ||
| Topical Calcineurin Inhibitors | 256 | ||
| Adjuvant Therapy | 256 | ||
| Referral to Specialists | 257 | ||
| Summary | 257 | ||
| Supplementary data | 257 | ||
| References | 257 | ||
| Diagnosis and Management of Psoriasis in Children | 261 | ||
| Key points | 261 | ||
| Introduction | 261 | ||
| Overview | 261 | ||
| Pathophysiology | 261 | ||
| Epidemiology | 262 | ||
| Prognosis | 262 | ||
| Clinical features | 262 | ||
| History | 262 | ||
| Physical Examination | 263 | ||
| Co-morbidities | 266 | ||
| Differential diagnosis | 269 | ||
| Diagnostic recommendations | 270 | ||
| Laboratory Studies | 270 | ||
| Radiology | 270 | ||
| Histology | 270 | ||
| Therapeutic recommendations | 271 | ||
| Pharmacologic Treatment | 271 | ||
| Nonpharmacologic Treatment | 274 | ||
| Surgical Treatment Options | 274 | ||
| Self-Management Strategies | 274 | ||
| Complications | 274 | ||
| Summary | 275 | ||
| References | 275 | ||
| Pediatric Melanoma, Moles, and Sun Safety | 279 | ||
| Key points | 279 | ||
| Introduction | 279 | ||
| Pediatric melanoma | 279 | ||
| Melanoma risk factors | 280 | ||
| Congenital nevi | 282 | ||
| Acquired banal and dysplastic nevi | 284 | ||
| Spitz nevi | 284 | ||
| Characteristic changes in nevi | 286 | ||
| Evaluation, treatment, and counseling | 286 | ||
| Summary | 289 | ||
| References | 289 | ||
| Diagnosis and Management of Nail Disorders in Children | 293 | ||
| Key points | 293 | ||
| Introduction | 293 | ||
| Normal nail anatomy | 293 | ||
| Onychomycosis | 294 | ||
| Melanonychia | 297 | ||
| Trachyonychia | 299 | ||
| Onychomadesis | 301 | ||
| Nail pitting | 303 | ||
| Summary | 304 | ||
| References | 304 | ||
| Diagnosis and Management of Morphea and Lichen Sclerosus and Atrophicus in Children | 309 | ||
| Key points | 309 | ||
| Introduction | 309 | ||
| Overview | 309 | ||
| Epidemiology | 310 | ||
| Pathophysiology | 310 | ||
| History | 310 | ||
| Clinical features | 310 | ||
| Physical examination | 312 | ||
| Comorbidities | 312 | ||
| Differential diagnosis | 313 | ||
| Diagnostic recommendations | 313 | ||
| Histology | 313 | ||
| Laboratory studies | 314 | ||
| Radiology | 314 | ||
| Therapeutic recommendations | 314 | ||
| Pharmacologic Treatment | 316 | ||
| Nonpharmacologic Treatment | 316 | ||
| Surgical treatment options | 316 | ||
| Prognosis | 317 | ||
| Summary | 317 | ||
| References | 317 | ||
| Diagnosis and Management of Cutaneous Vasculitis in Children | 321 | ||
| Key points | 321 | ||
| Introduction | 321 | ||
| Pathophysiology | 322 | ||
| Epidemiology | 322 | ||
| Clinical features | 322 | ||
| History | 322 | ||
| Diagnostic recommendations | 323 | ||
| Laboratory Studies | 323 | ||
| Histology | 323 | ||
| Therapeutic recommendations | 324 | ||
| Pharmacologic Treatment | 324 | ||
| Prognosis | 324 | ||
| Leukocytoclastic vasculitis | 324 | ||
| HSP | 324 | ||
| Introduction/overview | 324 | ||
| Pathophysiology | 325 | ||
| Epidemiology | 325 | ||
| Prognosis | 325 | ||
| Clinical features | 325 | ||
| History | 325 | ||
| Physical Examination | 325 | ||
| Differential Diagnosis | 327 | ||
| Diagnostic recommendations | 327 | ||
| Therapeutic recommendations | 328 | ||
| Pharmacologic Treatment | 328 | ||
| Complications | 329 | ||
| AHEI | 329 | ||
| Clinical features | 329 | ||
| History | 329 | ||
| Physical Examination | 330 | ||
| Differential Diagnosis | 330 | ||
| Diagnostic recommendations | 330 | ||
| Laboratory Studies | 330 | ||
| Histology | 331 | ||
| Therapeutic recommendations | 331 | ||
| Pharmacologic Treatment | 331 | ||
| Prognosis | 331 | ||
| UV | 331 | ||
| Clinical features | 331 | ||
| Diagnostic recommendations | 332 | ||
| Laboratory Studies | 332 | ||
| Histology | 332 | ||
| Therapeutic recommendations | 333 | ||
| Pharmacologic Treatment | 333 | ||
| Pediatric Vitiligo | 347 | ||
| Key points | 347 | ||
| Introduction | 347 | ||
| Epidemiology | 348 | ||
| Pathophysiology | 348 | ||
| Prognosis | 349 | ||
| Clinical features | 349 | ||
| History | 349 | ||
| Physical Examination | 351 | ||
| Comorbidities | 351 | ||
| Differential diagnosis | 352 | ||
| Diagnostic recommendations | 353 | ||
| Laboratory Studies | 353 | ||
| Radiology | 353 | ||
| Histology | 353 | ||
| Therapeutic recommendations | 353 | ||
| Pharmacologic Treatment | 353 | ||
| Topical therapies | 354 | ||
| Tacrolimus | 356 | ||
| Topical pimecrolimus | 357 | ||
| Corticosteroids and calcipotriene (topical vitamin D analogue) | 357 | ||
| Phototherapy and surgical therapies | 357 | ||
| Coordination of Care | 359 | ||
| Self-Management Strategies | 359 | ||
| Summary | 359 | ||
| References | 359 | ||
| Diagnosis and Management of Diaper Dermatitis | 367 | ||
| Key points | 367 | ||
| Introduction | 367 | ||
| Overview | 367 | ||
| Pathophysiology | 367 | ||
| Epidemiology | 368 | ||
| Prognosis | 368 | ||
| Clinical features | 368 | ||
| History | 368 | ||
| Physical Examination | 369 | ||
| Clinical Findings of Diaper Dermatitis | 369 | ||
| Comorbidities | 371 | ||
| Differential diagnosis | 371 | ||
| Inflammatory Conditions | 371 | ||
| Infectious Conditions | 374 | ||
| Nutritional Deficiencies | 375 | ||
| Other | 375 | ||
| Diagnostic recommendations | 376 | ||
| Laboratory Studies | 376 | ||
| Histology | 376 | ||
| Therapeutic recommendations | 376 | ||
| Pharmacologic Treatment | 377 | ||
| Topical corticosteroid therapy | 377 | ||
| Antifungal therapy | 377 | ||
| Antibacterial therapy | 378 | ||
| Decreasing bacterial colonization | 378 | ||
| Nonpharmacologic Treatment | 378 | ||
| Self-Management Strategies | 379 | ||
| Cleansing routine | 379 | ||
| Diapers | 379 | ||
| Wipes | 379 | ||
| Compresses | 379 | ||
| Complications | 380 | ||
| Summary | 380 | ||
| References | 380 | ||
| Diagnosis and Management of Infantile Hemangiomas | 383 | ||
| Key points | 383 | ||
| Introduction | 383 | ||
| Diagnosis | 384 | ||
| Epidemiology | 384 | ||
| Natural history | 387 | ||
| Complications | 391 | ||
| Multifocal IH | 392 | ||
| Complications associated with segmental IH | 394 | ||
| Therapy | 396 | ||
| Summary | 399 | ||
| References | 399 | ||
| Cutaneous Drug Reactions in the Pediatric Population | 403 | ||
| Key points | 403 | ||
| Overview | 403 | ||
| Pathophysiology | 405 | ||
| Epidemiology | 406 | ||
| Prognosis | 407 | ||
| Clinical features | 408 | ||
| Urticaria | 408 | ||
| Serum Sickness–Like Reactions | 409 | ||
| Maculopapular Exanthems | 409 | ||
| Drug reaction with eosinophilia and systemic symptoms | 411 | ||
| Vesiculobullous Eruptions (SJS and TEN) | 411 | ||
| Acute Generalized Exanthematous Pustulosis | 414 | ||
| Miscellaneous | 415 | ||
| Fixed drug eruption | 415 | ||
| Acneiform eruptions | 415 | ||
| Others | 415 | ||
| Differential diagnosis | 416 | ||
| Diagnostic recommendations | 417 | ||
| Laboratory Studies | 417 | ||
| Therapeutic recommendations | 420 | ||
| Nonpharmacologic Treatment | 420 | ||
| Pharmacologic Treatment | 420 | ||
| Summary | 420 | ||
| Acknowledgments | 421 | ||
| References | 421 | ||
| Diagnosis and Management of Alopecia in Children | 427 | ||
| Key points | 427 | ||
| Introduction | 427 | ||
| Overview | 427 | ||
| Pathophysiology | 428 | ||
| The history and physical examination | 428 | ||
| Review of common alopecias | 429 | ||
| Tinea Capitis | 429 | ||
| Overview | 429 | ||
| Epidemiology | 429 | ||
| Pathophysiology | 429 | ||
| Clinical appearance | 431 | ||
| Differential diagnosis | 431 | ||
| Prognosis | 431 | ||
| Diagnostic studies | 431 | ||
| Therapy | 432 | ||
| Other | 432 | ||
| AA | 432 | ||
| Epidemiology | 432 | ||
| Pathophysiology | 433 | ||
| Clinical appearance | 433 | ||
| Associations | 433 | ||
| Differential diagnosis | 433 | ||
| Prognosis | 433 | ||
| Diagnostic studies | 435 | ||
| Therapies | 435 | ||
| Traction Alopecia | 435 | ||
| Overview | 435 | ||
| Epidemiology | 436 | ||
| Pathophysiology | 436 | ||
| Clinical presentation | 436 | ||
| Differential diagnosis | 436 | ||
| Diagnostic considerations | 436 | ||
| Therapeutics | 436 | ||
| Prognosis | 437 | ||
| Telogen Effluvium | 437 | ||
| Overview | 437 | ||
| Epidemiology | 437 | ||
| Pathophysiology | 437 | ||
| Clinical presentation | 437 | ||
| Differential diagnosis | 438 | ||
| Diagnostic considerations | 438 | ||
| Therapeutics | 438 | ||
| Prognosis | 438 | ||
| Other | 438 | ||
| Trichotillomania/Trichotillosis | 438 | ||
| Overview | 438 | ||
| Epidemiology | 438 | ||
| Pathophysiology | 439 | ||
| Clinical presentation | 439 | ||
| Differential diagnosis | 439 | ||
| Diagnostic considerations | 439 | ||
| Therapeutics | 440 | ||
| Prognosis | 440 | ||
| Summary | 440 | ||
| References | 440 | ||
| Superficial Fungal Infections in Children | 443 | ||
| Key points | 443 | ||
| Introduction | 443 | ||
| Infection of the skin (tinea) | 444 | ||
| Clinical Features | 444 | ||
| Tinea corporis | 444 | ||
| Clinical variants of tinea corporis: tinea profunda and Majocchi granuloma | 445 | ||
| Tinea pedis | 445 | ||
| Tinea cruris | 446 | ||
| Tinea manuum | 446 | ||
| Tinea faciei | 447 | ||
| Variants of tinea faciei | 447 | ||
| Diagnostic Recommendations | 447 | ||
| Therapeutic Recommendations | 448 | ||
| Infection of the scalp/hair (tinea capitis) | 448 | ||
| Introduction | 448 | ||
| Clinical Features | 449 | ||
| Differential Diagnosis | 449 | ||
| Diagnostic Recommendations | 450 | ||
| Therapeutic Recommendations | 450 | ||
| Infection of the fingernails or toenails (tinea unguium or onychomycosis) | 451 | ||
| Introduction | 451 | ||
| Clinical Features | 451 | ||
| Differential Diagnosis | 451 | ||
| Diagnostic Recommendations | 452 | ||
| Therapeutic Recommendations | 452 | ||
| Id reactions | 452 | ||
| Pityriasis (tinea) versicolor | 453 | ||
| Introduction | 453 | ||
| Clinical Features | 453 | ||
| Differential Diagnosis | 453 | ||
| Diagnostic Recommendations | 453 | ||
| Therapeutic Recommendations | 454 | ||
| Summary | 455 | ||
| References | 455 | ||
| Cutaneous Bacterial Infections Caused by Staphylococcus aureus and Streptococcus pyogenes in Infants and Children | 457 | ||
| Key points | 457 | ||
| Introduction | 457 | ||
| Current epidemiology of S aureus and S pyogenes | 458 | ||
| Index | 479 |